Scientific comment on tumor suppressor p53 protein expression: prognostic significance in patients with low-risk myelodysplastic syndrome
AUTOR(ES)
Velloso, Elvira Deolinda Rodrigues Pereira
FONTE
Rev. Bras. Hematol. Hemoter.
DATA DE PUBLICAÇÃO
2014-06
RESUMO
Documentos Relacionados
- Tumor suppressor p53 protein expression: prognostic significance in patients with low-risk myelodysplastic syndrome
- Utility of the p53 mutant protein in patients with low-risk myelodysplastic syndrome
- Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein.
- Amphotericin B-related nephrotoxicity in low-risk patients
- Improving care of patients with low-risk differentiated thyroid carcinoma